ADAPTHEALTH CORP (AHCO) Stock Fundamental Analysis
USA - NASDAQ:AHCO - US00653Q1022 - Common Stock
9.22 USD
+0.11 (+1.21%)
9.22 USD
0 (0%)
AHCO gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. While AHCO is still in line with the averages on profitability rating, there are concerns on its financial health. AHCO scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
In the past year AHCO was profitable.
AHCO had a positive operating cash flow in the past year.
In multiple years AHCO reported negative net income over the last 5 years.
In the past 5 years AHCO always reported a positive cash flow from operatings.
1.2 Ratios
AHCO has a Return On Assets (1.66%) which is in line with its industry peers.
With a decent Return On Equity value of 4.73%, AHCO is doing good in the industry, outperforming 61.39% of the companies in the same industry.
AHCO's Return On Invested Capital of 4.66% is in line compared to the rest of the industry. AHCO outperforms 56.44% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AHCO is below the industry average of 9.19%.
The 3 year average ROIC (4.25%) for AHCO is below the current ROIC(4.66%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.66% | ||
| ROE | 4.73% | ||
| ROIC | 4.66% |
ROA(3y)-4%
ROA(5y)-3.64%
ROE(3y)-12.78%
ROE(5y)-15.4%
ROIC(3y)4.25%
ROIC(5y)3.76%
1.3 Margins
The Profit Margin of AHCO (2.29%) is better than 63.37% of its industry peers.
AHCO's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 8.10%, AHCO is in the better half of the industry, outperforming 75.25% of the companies in the same industry.
AHCO's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 24.25%, AHCO is in line with its industry, outperforming 50.49% of the companies in the same industry.
AHCO's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.1% | ||
| PM (TTM) | 2.29% | ||
| GM | 24.25% |
OM growth 3Y1.95%
OM growth 5Y11.03%
PM growth 3Y-23.99%
PM growth 5YN/A
GM growth 3Y4.28%
GM growth 5Y4.45%
2. Health
2.1 Basic Checks
AHCO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AHCO has been increased compared to 1 year ago.
The number of shares outstanding for AHCO has been increased compared to 5 years ago.
The debt/assets ratio for AHCO has been reduced compared to a year ago.
2.2 Solvency
AHCO has an Altman-Z score of 1.05. This is a bad value and indicates that AHCO is not financially healthy and even has some risk of bankruptcy.
AHCO's Altman-Z score of 1.05 is on the low side compared to the rest of the industry. AHCO is outperformed by 70.30% of its industry peers.
The Debt to FCF ratio of AHCO is 8.74, which is on the high side as it means it would take AHCO, 8.74 years of fcf income to pay off all of its debts.
AHCO has a Debt to FCF ratio (8.74) which is in line with its industry peers.
AHCO has a Debt/Equity ratio of 1.27. This is a high value indicating a heavy dependency on external financing.
AHCO has a worse Debt to Equity ratio (1.27) than 65.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | 8.74 | ||
| Altman-Z | 1.05 |
ROIC/WACC0.6
WACC7.75%
2.3 Liquidity
AHCO has a Current Ratio of 1.33. This is a normal value and indicates that AHCO is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.33, AHCO is in line with its industry, outperforming 42.57% of the companies in the same industry.
AHCO has a Quick Ratio of 1.09. This is a normal value and indicates that AHCO is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.09, AHCO is not doing good in the industry: 62.38% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.33 | ||
| Quick Ratio | 1.09 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 122.46% over the past year.
AHCO shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.23% yearly.
Looking at the last year, AHCO shows a very negative growth in Revenue. The Revenue has decreased by -20.04% in the last year.
AHCO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 43.84% yearly.
EPS 1Y (TTM)122.46%
EPS 3Y10.23%
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)-20.04%
Revenue growth 3Y9.93%
Revenue growth 5Y43.84%
Sales Q2Q%-0.7%
3.2 Future
AHCO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.56% yearly.
Based on estimates for the next years, AHCO will show a small growth in Revenue. The Revenue will grow by 7.27% on average per year.
EPS Next Y60.37%
EPS Next 2Y38.06%
EPS Next 3Y31.58%
EPS Next 5Y26.56%
Revenue Next Year-0.24%
Revenue Next 2Y3.24%
Revenue Next 3Y5.58%
Revenue Next 5Y7.27%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 29.74 indicates a quite expensive valuation of AHCO.
The rest of the industry has a similar Price/Earnings ratio as AHCO.
Compared to an average S&P500 Price/Earnings ratio of 27.20, AHCO is valued at the same level.
Based on the Price/Forward Earnings ratio of 8.06, the valuation of AHCO can be described as reasonable.
Based on the Price/Forward Earnings ratio, AHCO is valued cheaper than 94.06% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.71. AHCO is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.74 | ||
| Fwd PE | 8.06 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, AHCO is valued cheaper than 93.07% of the companies in the same industry.
97.03% of the companies in the same industry are more expensive than AHCO, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.4 | ||
| EV/EBITDA | 5.01 |
4.3 Compensation for Growth
AHCO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AHCO has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as AHCO's earnings are expected to grow with 31.58% in the coming years.
PEG (NY)0.49
PEG (5Y)N/A
EPS Next 2Y38.06%
EPS Next 3Y31.58%
5. Dividend
5.1 Amount
AHCO does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
9.22
+0.11 (+1.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners91.21%
Inst Owner Change2.67%
Ins Owners1.83%
Ins Owner Change1.38%
Market Cap1.25B
Analysts81.43
Price Target13.39 (45.23%)
Short Float %9.57%
Short Ratio9.86
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-768.16%
Min EPS beat(2)-1325.49%
Max EPS beat(2)-210.83%
EPS beat(4)1
Avg EPS beat(4)-378.06%
Min EPS beat(4)-1325.49%
Max EPS beat(4)35.5%
EPS beat(8)2
Avg EPS beat(8)-338.41%
EPS beat(12)3
Avg EPS beat(12)-237.75%
EPS beat(16)3
Avg EPS beat(16)-191.06%
Revenue beat(2)0
Avg Revenue beat(2)-1.33%
Min Revenue beat(2)-2.38%
Max Revenue beat(2)-0.28%
Revenue beat(4)1
Avg Revenue beat(4)-0.94%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)1.28%
Revenue beat(8)3
Avg Revenue beat(8)-0.44%
Revenue beat(12)5
Avg Revenue beat(12)-0.65%
Revenue beat(16)7
Avg Revenue beat(16)-0.18%
PT rev (1m)1.94%
PT rev (3m)1.94%
EPS NQ rev (1m)-13.99%
EPS NQ rev (3m)-9.13%
EPS NY rev (1m)23.58%
EPS NY rev (3m)12.3%
Revenue NQ rev (1m)-0.34%
Revenue NQ rev (3m)-1.2%
Revenue NY rev (1m)-0.51%
Revenue NY rev (3m)-0.81%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.74 | ||
| Fwd PE | 8.06 | ||
| P/S | 0.38 | ||
| P/FCF | 5.4 | ||
| P/OCF | 2.26 | ||
| P/B | 0.79 | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.01 |
EPS(TTM)0.31
EY3.36%
EPS(NY)1.14
Fwd EY12.4%
FCF(TTM)1.71
FCFY18.53%
OCF(TTM)4.08
OCFY44.28%
SpS23.95
BVpS11.61
TBVpS-8.94
PEG (NY)0.49
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.66% | ||
| ROE | 4.73% | ||
| ROCE | 6.69% | ||
| ROIC | 4.66% | ||
| ROICexc | 4.8% | ||
| ROICexgc | 17.76% | ||
| OM | 8.1% | ||
| PM (TTM) | 2.29% | ||
| GM | 24.25% | ||
| FCFM | 7.13% |
ROA(3y)-4%
ROA(5y)-3.64%
ROE(3y)-12.78%
ROE(5y)-15.4%
ROIC(3y)4.25%
ROIC(5y)3.76%
ROICexc(3y)4.34%
ROICexc(5y)3.9%
ROICexgc(3y)17.05%
ROICexgc(5y)18.83%
ROCE(3y)6.1%
ROCE(5y)5.39%
ROICexcg growth 3Y0.25%
ROICexcg growth 5Y-13.24%
ROICexc growth 3Y18.04%
ROICexc growth 5Y-2.96%
OM growth 3Y1.95%
OM growth 5Y11.03%
PM growth 3Y-23.99%
PM growth 5YN/A
GM growth 3Y4.28%
GM growth 5Y4.45%
F-Score7
Asset Turnover0.72
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | 8.74 | ||
| Debt/EBITDA | 3.16 | ||
| Cap/Depr | 87.27% | ||
| Cap/Sales | 9.91% | ||
| Interest Coverage | 2.35 | ||
| Cash Conversion | 87.62% | ||
| Profit Quality | 311.22% | ||
| Current Ratio | 1.33 | ||
| Quick Ratio | 1.09 | ||
| Altman-Z | 1.05 |
F-Score7
WACC7.75%
ROIC/WACC0.6
Cap/Depr(3y)94.46%
Cap/Depr(5y)82.09%
Cap/Sales(3y)11.04%
Cap/Sales(5y)9.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)122.46%
EPS 3Y10.23%
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y60.37%
EPS Next 2Y38.06%
EPS Next 3Y31.58%
EPS Next 5Y26.56%
Revenue 1Y (TTM)-20.04%
Revenue growth 3Y9.93%
Revenue growth 5Y43.84%
Sales Q2Q%-0.7%
Revenue Next Year-0.24%
Revenue Next 2Y3.24%
Revenue Next 3Y5.58%
Revenue Next 5Y7.27%
EBIT growth 1Y-23.13%
EBIT growth 3Y12.08%
EBIT growth 5Y59.71%
EBIT Next Year179.42%
EBIT Next 3Y47.59%
EBIT Next 5YN/A
FCF growth 1Y960.55%
FCF growth 3Y48.23%
FCF growth 5Y43.24%
OCF growth 1Y28.27%
OCF growth 3Y25.26%
OCF growth 5Y55.08%